• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Adult Immunization Plans

The National Adult Immunization Plan (NAIP) provides an overview of actions needed to be undertaken by federal and nonfederal partners to protect public health and achieve optimal prevention of infectious diseases and their consequences through vaccination of adults. The plan establishes four key goals, each of which is supported by objectives and strategies to guide implementation through 2020.

The companion document, the National Adult Immunization Plan: A Path to Implementation facilitates action on the goals outlined in the NAIP by identifying 8 implementation priorities and suggesting potential activities to support each priority.

Click Each Goal to Find Out More

Learn more about Goal 1 - Infrastructure
Goal 1:

Strengthen the adult immunization infrastructure

Learn more about Goal 2 - Access
Goal 2:

Improve access to adult vaccines

Learn more about Goal 3 - Demand
Goal 3:

Increase community demand for adult immunizations

Learn more about Goal 4 - Innovate
Goal 4:

Foster innovation in adult vaccine development and vaccination related technologies

The Importance of Adult Immunization

Adult vaccination rates remain low in the United States and far below national targets, leaving millions of adults susceptive to vaccine preventable diseases and their potentially severe consequences. Additionally, with the aging of the U.S. population, the public health impact of vaccine-preventable diseases and their complications in adults is likely to grow.

The NAIP outlines ways we can work together to overcome barriers to adult immunization, strengthen infrastructure and improve adult vaccination rates.

Share Your Story

Adult getting vaccinated

Many stakeholders play a role in improving the adult immunization system. Tell us how you or your organization are working to uphold the goals of the National Adult Immunization Plan or the Path to Implementation guidance!

Click here to share your story



Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed on June 10, 2019